Join our webinar on November 12 to learn how Kashi Clinical Laboratories has quickly operationalized a custom saliva SARS-CoV-2 testing protocol by leveraging the BGI/MGI’s clinical lab partnership program. Featured speakers are Dr. Zahra Kashi (CEO/Founder) and Mrs. Dena Balbach (Chief Business Officer).
They will discuss an advanced approach that has enabled their high-complexity genetic testing laboratory to operationalize in COVID-19 molecular testing within weeks and the continued innovations that are required to help combat the deadly novel coronavirus.
Their discussions will also include:
- Adoption of automation that enabled high-throughput, accurate testing
- How they implemented a saliva-based collection protocol – the game changer for pathogen surveillance testing
- Direct-to-consumer saliva testing – the next step to extend community coverage
- Expansion of testing capacity through pooled samples
- Partnership roles contributed by BGI and MGI
